Literature DB >> 7526972

RNA expression of complement regulatory proteins in human brain tumors.

N Shinoura1, S C Heffelfinger, M Miller, O I Shamraj, N H Miura, J J Larson, N DeTribolet, R E Warnick, J J Tew, A G Menon.   

Abstract

The expression of complement regulatory proteins (CRP) on the surface of neoplastic cells has been proposed as a mechanism by which these cells evade immune surveillance. We have examined the RNA expression of the genes that encode 5 kinds of CRP in various human brain tumors to determine whether CRP expression might play a role in the malignant progression of these tumors. The benign and atypical meningiomas, and the astrocytomas showed high expression of SP-40,40, low expression of CD59, and barely detectable expression of CD46, CD55 and S-protein. The benign and atypical menigiomas showed significantly greater expression of SP-40,40 at the RNA level when compared to malignant meningiomas. This study describes the mRNA expression of meningiomas, astrocytomas, tumor cell lines and normal human tissues.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7526972     DOI: 10.1016/0304-3835(94)90072-8

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  7 in total

Review 1.  Oncolytic measles virus strains in the treatment of gliomas.

Authors:  Cory Allen; Georgia Paraskevakou; Chunsheng Liu; Ianko D Iankov; Pavlos Msaouel; Paula Zollman; Rae Myers; Kah Whye Peng; Stephen J Russell; Evanthia Galanis
Journal:  Expert Opin Biol Ther       Date:  2008-02       Impact factor: 4.388

2.  Gene expression analysis in a canine model of X-linked Alport syndrome.

Authors:  Kimberly A Greer; Marnie A Higgins; Melissa L Cox; Timothy P Ryan; Brian R Berridge; Clifford E Kashtan; George E Lees; Keith E Murphy
Journal:  Mamm Genome       Date:  2006-09-08       Impact factor: 2.957

3.  Expression of the complement regulatory proteins decay accelerating factor (DAF, CD55), membrane cofactor protein (MCP, CD46) and CD59 in the normal human uterine cervix and in premalignant and malignant cervical disease.

Authors:  K L Simpson; A Jones; S Norman; C H Holmes
Journal:  Am J Pathol       Date:  1997-11       Impact factor: 4.307

4.  Expression of complement membrane regulators membrane cofactor protein (CD46), decay accelerating factor (CD55), and protectin (CD59) in human malignant gliomas.

Authors:  A Mäenpää; S Junnikkala; J Hakulinen; T Timonen; S Meri
Journal:  Am J Pathol       Date:  1996-04       Impact factor: 4.307

5.  A gene expression signature predicts recurrence-free survival in meningioma.

Authors:  Adriana Olar; Lindsey D Goodman; Khalida M Wani; Nicholas S Boehling; Devi S Sharma; Reema R Mody; Joy Gumin; Elizabeth B Claus; Frederick F Lang; Timothy F Cloughesy; Albert Lai; Kenneth D Aldape; Franco DeMonte; Erik P Sulman
Journal:  Oncotarget       Date:  2018-02-15

6.  Complement activation in astrocytomas: deposition of C4d and patient outcome.

Authors:  Katri Mäkelä; Pauli Helén; Hannu Haapasalo; Timo Paavonen
Journal:  BMC Cancer       Date:  2012-12-01       Impact factor: 4.430

7.  Detection and benchmarking of somatic mutations in cancer genomes using RNA-seq data.

Authors:  Alexandre Coudray; Anna M Battenhouse; Philipp Bucher; Vishwanath R Iyer
Journal:  PeerJ       Date:  2018-07-31       Impact factor: 2.984

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.